Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation.
Am J Cardiol
; 93(4): 509-11, 2004 Feb 15.
Article
em En
| MEDLINE
| ID: mdl-14969639
ABSTRACT
Patients on long-term anticoagulation who require interruption of therapy for surgery may receive "bridging therapy" with continuous-infusion unfractionated heparin or low-molecular-weight heparin (LMWH). We estimated the costs of bridging therapy with (1) LMWH self-administered at home, (2) LMWH administered by a nurse to patients at home, and (3) continuous-infusion unfractionated heparin in the hospital. For surgeries requiring an overnight stay, bridging costs are estimated to be 672, 933, and 3,816 US dollars, respectively, for each of these strategies.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Heparina
/
Heparina de Baixo Peso Molecular
/
Anticoagulantes
Idioma:
En
Ano de publicação:
2004
Tipo de documento:
Article